Policy Briefings

SK pharmteco Launches Catalyst Kit for Continuous API Manufacturing

SK pharmteco Supports GEMMABio’s Phase 1/2 Trial of SMA1 Gene Therapy

FamiCord AG Signs Manufacturing Agreement With VERIGRAFT for P-TEV

Altruist Biologics Suzhou Facility Passes EMA GMP Inspection

Recipharm Partners With CanVirex to Scale Oncolytic Measles Virus Manufacturing

Flen Health Selects AGC Biologics for Wound Therapy Manufacturing

Cellares Partners With SNUH on Automated PNH Cell Therapy Manufacturing

KinetiSol Receives FDA Advanced Manufacturing Technology Designation

Corealis Pharma Partners With PhinC Group on Oral Drug Development

Sharp Services Expands Autoinjector and Pen Assembly Capacity

Sanner Rebrands Gilero and Expands Chicago Innovation Facility

WuXi XDC Marks GMP Release of 25,000-Sq.-Meter Singapore Site

Made Scientific Acquires 85,000-Sq.-Ft. Cell Therapy Manufacturing Facility

Bespak and Upperton Partner on Nasal Drug Development and Manufacturing

Gaelic Laboratories Launches Dual-Source Beta-Lactam Strategy With Athlone

Andelyn Biosciences Begins Commercial Manufacturing of FDA-Approved Fayuvi

mAbxience to Develop and Manufacture Emicizumab Biosimilar for Sandoz

GBI Biomanufacturing Launches SmartScale GMP Platform for Early-Stage Biologics